Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Infectious Diseases
  4. HIV & AIDS
  5. Treatment

Treatment

  • Antimicrobial Stewardship (13)
  • COVID-19 (13)
  • Fever (4)
  • Fungal Infections (8)
  • H1N1 (Swine) Influenza (38)
  • HIV & AIDS (70)
    • Drug-Induced Toxicity (6)
    • Drug Interactions (11)
    • HIV Screening and Testing (9)
    • Opportunistic Infection Drug Therapies (3)
    • Prevention (30)
    • Treatment (22)
      • Antiviral Drug Therapies (20)
      • Selecting a Treatment Regimen (15)
  • Infections (46)
  • Lower Respiratory Tract Infections (68)
  • Measles (2)
  • MRSA (4)
  • Other (151)
  • Resources (414)
  • STIs (81)
  • Skin/Soft Tissue Infections (51)
  • Thrush (2)
  • Travel Medicine (65)
  • Upper Respiratory Tract Infections (146)
  • Vaccines (237)
  • West Nile Virus (8)
1 - 15 of 22 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: New Drugs: Vocabria (Cabotegravir) and Cabenuva (Cabotegravir/Rilpivirine) November 2020
Article: Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva November 2020
Chart: New Formulation: Dovato (Dolutegravir-Lamivudine) November 2019
Article: Be Prepared to Dispense Dovato, a New Combo Med for HIV November 2019
Chart: New Drug: Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) October 2018
Chart: New Drug: Juluca (Dolutegravir/Rilpivirine) October 2018
Article: Expect to See More HIV Meds Containing "Integrase Inhibitors" October 2018
Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, 2018 June 2018
Commentary: Symtuza Approved in Canada June 2018
Article: Symtuza and Biktarvy Will Join Other Combos for Treating HIV June 2018
Other: General Principles of HIV Drug Therapy for Pharmacy Technicians September 2016
Other: HIV Drug Therapy Update for Pharmacy Technicians September 2016
Article: Watch for HIV Patients Getting Both the Old and New Forms of Tenofovir September 2016
Other: Truvada for PrEP (February 2016) May 2016
Article: Stress Adherence in Patients Taking Truvada for Pre-Exposure Prophylaxis (PrEP) May 2016
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved